JAMA Network | JAMA Psychiatry | Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study on September 12, 2015 Get link Facebook X Pinterest Email Other Apps JAMA Network | JAMA Psychiatry | Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study Comments
Comments
Post a Comment